Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia
Michael Francis, Tom A. Hummer, Emily Liffick, Jenifer L. Vohs, Nikki Mehdiyoun, Andrew Visco, Ziyi Yang, Richard J. Kovacs, Ying Zhang, Alan Breier
Topics & Concepts
FingolimodFractional anisotropyWhite matterMedicineInternal medicinePlaceboAgonistSchizophrenia (object-oriented programming)Multiple sclerosisSchizoaffective disorderPsychologyPsychosisPsychiatryPathologyReceptorMagnetic resonance imagingRadiologyAlternative medicineAdvanced Neuroimaging Techniques and ApplicationsMultiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling